Sponsor Pipeline

Autobahn Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06633016 Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY) Major Depressive Disorder Recruiting
NCT06869187 Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With… Bipolar Disorder Depression Active, Not Recruiting
Disease Areas
Get alerts when Autobahn Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free